AURX 8-K 2026-08-17

Nuo Therapeutics, Inc. (AURX) 8-K dated 2026-08-17 — accession 0001437749-26-028109. This URL is the filing, not the AURX hub.

Nuo Therapeutics, Inc. (AURX) is a biotechnology company listed on US.

Nuo Therapeutics, Inc. filed a 8-K on 2026-08-17. Accession 0001437749-26-028109.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AURX revenue for 2026-06-30 was $3.1M. Net income was -$896.1K. AURX currently screens at market cap $72.1M.

Not investment advice. The AURX SEC hub lists recent forms. The stock page is the research view.